Drug
Adynovate
Adynovate is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (50.0%)
Phase 41 (50.0%)
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_3
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A
NCT05707351
recruitingphase_4
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
NCT04690322
completed
ADYNOVATE Drug Use-Results Survey
NCT03169972
completed
Post Marketing Surveillance Study for ADYNOVATE in South Korea
NCT03824522
Clinical Trials (4)
Showing 4 of 4 trials
NCT05707351Phase 3
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A
NCT04690322Phase 4
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
NCT03169972
ADYNOVATE Drug Use-Results Survey
NCT03824522
Post Marketing Surveillance Study for ADYNOVATE in South Korea
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4